Polygenic risk-based prediction of heart failure in young patients with atrial fibrillation.
作者信息
Homhuan Parichatra, Kour Manpreet
机构信息
Department of Cardiology, Royal Free Hospital, Pond St, London NW3 2QG, UK.
出版信息
Europace. 2025 Sep 1;27(9). doi: 10.1093/europace/euaf138.
Abstract
摘要
相似文献
1
Polygenic risk-based prediction of heart failure in young patients with atrial fibrillation.基于多基因风险的年轻房颤患者心力衰竭预测
Europace. 2025 Sep 1;27(9). doi: 10.1093/europace/euaf138.
2
Polygenic risk-based prediction of heart failure in young patients with atrial fibrillation: an analysis from UK Biobank.基于多基因风险的年轻房颤患者心力衰竭预测：来自英国生物银行的分析。
Europace. 2025 Jul 1;27(7). doi: 10.1093/europace/euaf104.
3
A polygenic risk score of atrial fibrillation improves prediction of lifetime risk for heart failure.多基因房颤风险评分可改善心力衰竭终生风险预测。
ESC Heart Fail. 2024 Apr;11(2):1086-1096. doi: 10.1002/ehf2.14665. Epub 2024 Jan 22.
4
Proteomic Signatures for Risk Prediction of Atrial Fibrillation.用于心房颤动风险预测的蛋白质组学特征
Circulation. 2025 Jul 29;152(4):217-229. doi: 10.1161/CIRCULATIONAHA.124.073457. Epub 2025 May 22.
5
Combining polygenic and clinical risk scores in atrial fibrillation risk prediction: Implications for population screening.在心房颤动风险预测中结合多基因和临床风险评分：对人群筛查的意义。
Heart Rhythm. 2025 Aug;22(8):1906-1914. doi: 10.1016/j.hrthm.2025.04.032. Epub 2025 Apr 25.
6
External Validation of the REACT-HF Score for Predicting Heart Failure in Patients With Atrial Fibrillation.用于预测心房颤动患者心力衰竭的REACT-HF评分的外部验证
J Am Heart Assoc. 2025 Sep 2;14(17):e043058. doi: 10.1161/JAHA.125.043058. Epub 2025 Aug 29.
7
Trends in mortality in people with heart failure and atrial fibrillation: a population-based cohort study.心力衰竭合并心房颤动患者的死亡率趋势：一项基于人群的队列研究。
Lancet Healthy Longev. 2025 Aug;6(8):100734. doi: 10.1016/j.lanhl.2025.100734. Epub 2025 Aug 13.
8
Prediction of atrial and ventricular arrhythmias using multiple cardiovascular risk-factor polygenic risk scores.使用多种心血管危险因素多基因风险评分预测心房和心室心律失常。
Heart Rhythm. 2025 Sep;22(9):2361-2371. doi: 10.1016/j.hrthm.2024.12.017. Epub 2024 Dec 15.
9
Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study.2000 年至 2022 年期间，丹麦全国范围内基于人群的队列研究中，房颤及其并发症的终生风险的时间趋势。
BMJ. 2024 Apr 17;385:e077209. doi: 10.1136/bmj-2023-077209.
10
Propafenone- vs. amiodarone-associated adverse cardiac outcomes in patients with atrial fibrillation and heart failure.房颤合并心力衰竭患者中普罗帕酮与胺碘酮相关的不良心脏结局
Br J Clin Pharmacol. 2025 Sep;91(9):2567-2575. doi: 10.1002/bcp.70068. Epub 2025 Apr 27.
本文引用的文献
1
Polygenic risk-based prediction of heart failure in young patients with atrial fibrillation: an analysis from UK Biobank.基于多基因风险的年轻房颤患者心力衰竭预测：来自英国生物银行的分析。
Europace. 2025 Jul 1;27(7). doi: 10.1093/europace/euaf104.
Zotero 插件